Prodromal Parkinsonian Features in GBA1 Mutation Carriers

Plain-language summary

This study aims to identify early (prodromal) signs of Parkinson's disease in people who carry a GBA1 gene mutation (carriers of Gaucher disease). It enrolls people who are willing to participate, excluding those with a Parkinson's diagnosis or dementia. It is a study with no assigned phase and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Shaare Zedek Medical Center

Intervention

The investigators aim to identify prodromal PD in a cohort of carriers of Gaucher disease.

Start date

5/16/2017

Estimated completion

12/31/2030

Countries

Israel

Related genes

Locations

• Jerusalem, Israel

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Willing to participate

Exclusion Criteria:

* PD patients
* Dementia